Non-Surgical Treatment of Hair Loss and Professional Ethics in Hair Transplantation

Spanish Language Webinar 1

Non-Surgical Treatment of Hair Loss
and Professional Ethics in Hair Transplantation

Available on Demand

Recorded on: Thursday, May 29, 2025
Moderator: Dr. Alejandro González Quiroz | Mexico
Co-Moderator: Dr. Guillermo Guerrero | Mexico

Cost: ISHRS Members – Free | Pending ISHRS Members – $25 USD | Non-members – $25 USD

Register here: https://compass.ishrs.org/events/tratamiento-no-quirrgico-de-la-cada-del-cabello/register

Title: Non-Surgical Treatment of Hair Loss and Professional Ethics in Hair Transplantation

Program Description

The two-hour webinar titled “Non-Surgical Treatment of Hair Loss and Professional Ethics in Hair Transplantation” aims to reinforce fundamental knowledge of non-surgical treatments to treat hair loss. Participants will gain advanced insights into the diagnostic tools, the underlying causes of hair loss, and the available treatment options. These treatments include topical therapies, mesotherapy, laser technologies, and nutritional supplementation. Additionally, the webinar addresses ethical considerations for hair
transplantation and equips clinicians with strategies to manage patient expectations responsibly.

Professional Practice Gap

As the non-surgical management of alopecia becomes increasingly intricate, significant clinical gaps persist in effectively diagnosing and treating the condition. It is essential for professionals to have a comprehensive understanding of the causes, diagnosis and treatment of alopecia, along with an understanding of current options for non-surgical management. It is also important to for clinicians to have a sound understanding of ethical considerations in determining candidacy for hair transplantation and strategies to manage patient expectations.

The training in this webinar will teach physicians to comprehensively approach hair loss, improving the quality of treatment and improving patient outcomes.

Educational Need Description

The webinar addresses this gap by delivering targeted education on:

1. Diagnostic tools available to aid in the accurate diagnosis of alopecia.
2. The underlying causes of hair loss, and the impact of hormonal factors.
3. Non-surgical treatment options for alopecia, including topical and oral treatments, mesotherapy, laser technologies and nutritional supplements.
4. Ethical considerations for hair transplantation and management of patient expectations.

Learning Objectives

By the end of this webinar, participants will be able to:

1. Identify the diagnostic tools available to accurately diagnose alopecia and select appropriate treatment.
2. Evaluate the role of endocrinological and hormonal factors in the development and management of alopecia.
3. Describe recent advancements in systemic and topical therapeutic options, including their indications and contraindications.
4. Investigate the clinical efficacy and practical integration of mesotherapy options in alopecia management.
5. Apply evidence-based knowledge of LED laser and low-power laser (LLT) technologies to complement treatment regimens.
6. List key nutritional deficiencies affecting alopecia and formulate supplementation protocols to optimize treatment outcomes.
7. Apply communication strategies to educate patients on realistic outcomes from hair transplants, emphasizing medical ethics and professional responsibility.

Program Schedule

12:00PM – Welcome and Program Introduction
Alejandro González Quiroz, MD | Mexico
Guillermo Guerrero, MD | Mexico

12:10 PM – Classification and Diagnosis of Alopecia
Renata Lages, MD | Brazil

12:20 PM – Study of Alopecia from the Endocrinological and Hormonal Perspective
Patricia Carmona, MD | Mexico

12:30 PM – New Developments in Topical and Oral Treatment of Alopecia
Luis Sánchez Dueñas, MD | Mexico

12:40 PM – Question and Answer Session

12:50 PM – Mesotherapy, is it Necessary in my Clinical Practice?
Miguel Martí, MD | Argentina

1:00 PM – Technologies Applied in Trichology: LED Laser, Low Power Laser (LLT), Among Others
Lizet Rojano, MD | Colombia

1:10 PM – Nutritional Supplementation in Alopecia
Roxana Castañeda, MD | Mexico

1:20 PM – When to Consider a Hair Transplant; a Patient and a Surgeon’s Perspective
Carolina Palacio, MD | Colombia

1:30 PM – How to Educate Patients about Real Expectations for Hair Transplants
Leoncio Moncada, MD, FISHRS | Venezuela

1:40 PM – Final Q&A Session and Closing Remarks

1:55 PM – Closing remarks and key conclusions

Assessment Methodology

• Live Q&A Sessions: Encourage interaction and clarify key concepts.
• Participant Feedback Form: Evaluate the relevance, quality, and applicability of the program.

Disclosures of Relevant Financial Relationships of Planners and Faculty

The following individuals have no relevant financial relationships with ineligible companies to disclose:

Planners

Alejandro Gonzalez Quiroz, MD – Planner & Moderator
Guillermo Guerrero, MD – Planner & Moderator
Marie Schambach, MD, FISHRS – Planner & Faculty
Victoria Ceh, MPA – Planner & Manager
Martha Contreras, MD – Planner
Melanie Stancampiano – Planner & Manager
Blanca Mejia – Planner & Manager
Eileen Hansen – Planner

Faculty

Lizet Rojano Fritz, MD
Roxana Castañeda Yépiz, MD
Leoncio Moncada, MD, FISHRS
Renata Lages, MD

The following individuals have relevant financial relationships:

Planners

None

Faculty

Luis Sánchez Dueñas, MD

• Speaker: Pierre Fabre, Ducray, Darrow, ISDIN, CARNOT Panalab, Dercos Vichy, Pfizer, Lilly
• Consultant: Cantabria Labs, Up Pharma

Miguel Martí, MD

• Medical Advisor: L’Oréal, Vichy, Dercos, Eucerin
• Consultant and Speaker: Raffo, Lilly, Casasco, Ducray, Skintegrity
• Speaker: Carnot Panalab, Cantabria Labs, Genové Dermatologics

All of the relevant financial relationships listed for these individuals have been mitigated.

References to Support Educational Need

1. Alvarez M, Amante H, Müller P. . Oral minoxidil vs topical minoxidil for male androgenetic alopecia a randomize clinical trial. 2024 April. JAMA Dermatol doi: 10.1001/jamadermatol.2024.0284.
2. Gupta, A, etal. Relative efficacy of minoxidil and the 5 alpha reductase inhibitors in androgenetic alopecia treatment of male patient: A new meta-analysis. JAMA Dermatol
3. Rajpul R. The concept of cyclical nutrition therapy for hair growth which can be applied for wellness. J Nutr Food Sci 2017,7:615.
4. Rutkowski M, Grzegorezky K. Adverse effects of antioxidative vitamins, Int J Occup Med Environ Health 2012,25:105-21.
5. Marzban, Sima & Amani, Bahman & Asgharzadeh, Asra. (2017). Safety and Efficacy of Mesotherapy in the Treatment of Androgenetic Alopecia: A Systematic Review. Health Technology Assessment in Action. 1. 10.5812/htaa.14078.
6. Mysore, Venkataram. (2010). Mesotherapy in Management of Hairloss – Is it of Any Use? International journal of trichology. 2. 45-6. 10.4103/0974-7753.66914.
7. Miteva M, Tosti A. Hair and scalp dermatoscopy. J Am Acad Dermatol. 2012;67(5):1040-1048. Published online March 8, 2012.
   doi:10.1016/j.jaad.2012.02.013
8. Avci, Pinar & Gupta, Gaurav & Clark, Jason & Wikonkal, Norbert & Hamblin, Michael. (2014). Low-Level Laser (Light) Therapy (LLLT) for treatment of hair loss. Lasers in surgery and medicine. 46. 10.1002/lsm.22170.
9. Ethical considerations in the treatment of frontal fibrosing alopecia: Addressing a Patient’s preference for hair transplantation over medical managementAgarwal, Priya et al.Journal of the American Academy of Dermatology, Volume 0, Issue 0
10. Williams, Greg. (2016). The Ethics and Advertising of Hair Transplant Surgery in the United Kingdom. International Society of Hair Restoration Surgery. 26. 220-221. 10.33589/26.5.0220.